World Molecular Diagnostics Market 2017-2021: Molecular Assays, Including Cancer Tests, NAT Blood Screening, Transplantation Testing, Histology Testing and Inherited Disease Testing

Dublin, March 08, 2017 -- Research and Markets has announced the addition of the "The World Market for Molecular Diagnostics, 7th Edition (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases)" report to their offering.

This report, The Market for Molecular Diagnostics, examines the current state for molecular assays, including cancer tests, NAT blood screening, transplantation testing, histology testing and inherited disease testing. Market size and forecasts are provided to 2021 for major segments and several subsegments. Profiles of operators and market share is provided.

Key Topics Covered:

1: Executive Summary
Molecular Diagnostic Technologies
Molecular Diagnostics In Healthcare
Global Molecular Diagnostics Market
Major Conclusions

2: Introduction To Clinical Molecular Diagnostics
Nucleic Acid Amplification Test (Naat) Technologies
Real-Time Pcr (Qpcr)
Isothermal Amplification
Trends In Nucleic Acid Amplification Testing And Emerging Technologies
Microarrays
Trends In Microarray Testing
In Situ Hybridization (Ish)
Trends In In Situ Hybridization Testing
Sequencing
Trends In Clinical Sequencing
Conclusions

3: Molecular Diagnostics In Healthcare
Reimbursement Environment For Molecular Diagnostics
Molecular Diagnostics And The Clinical Utility Standard
Laboratory-Developed Tests Are Here To Stay
Conclusions

4: Market For Molecular Infectious Disease Diagnostics
Market Analysis
Ct/Ng, Hpv And Women's Health
Hepatitis
Hiv
Hospital-Acquired Infections (Hais) And Sepsis
Respiratory
Tuberculosis
Conclusions

5: Market For Molecular Blood Transfusion Diagnostics
Market Analysis
New Infectious Disease Threats And Assay Introduction
Conclusions

6: Market For Molecular Histology And Cytology Diagnostics
Market Analysis
Rna In Molecular Histology
Cish And Other Reagent Chemistries
Prenatal Testing Moves To Nipt
Conclusions

7: Market For Molecular Cancer Diagnostics
Introduction
Bringing Molecular Resolution To Cancer Diagnostics
Tissue-Based Diagnostics, Companion Assays And The Status Quo In Ivd
Market Analysis
Conclusions

8: Market For Molecular Transplant Diagnostics
Introduction
Market Analysis
Technological Shift To Next-Generation Sequencing And Real-Time Pcr
Conclusions

9: Market For Molecular Diagnostics In Inherited Diseases
Market Analysis
Thrombophilia And Coagulation Markers
Autism
Alzheimer's Disease
Cardiovascular Disease
Diabetes
Psychiatric Disorders
Gastrointestinal Conditions
Other Autoimmune Diseases
Conclusions

10: Molecular Diagnostics Market Summary And Major Conclusions
Market Summary
Major Conclusions

11: Company Profiles

• Abbott Diagnostics
• Advanced Cell Diagnostics
• Affymetrix (Thermo Fisher Scientific)
• Agilent Technologies
• Amoy Diagnostics
• Applied Spectral Imaging
• Beckman Coulter (Danaher)
• Becton, Dickinson & Co. (Bd)
• Berry Genomics
• Biocartis
• Biomérieux
• Bio-Rad Laboratories
• Bioview
• Caredx
• Cepheid (Danaher)
• Covaris
• Dako (Agilent Technologies)
• Eiken Chemical
• Epigenomics
• Exosome Diagnostics
• Genmark Diagnostics
• Hologic
• Illumina
• Immucor
• Luminex Corporation
• Meridian Bioscience
• Nanosphere (Luminex)
• Nanostring Technologies
• Qiagen
• Quidel
• Roche Diagnostics
• Siemens Healthcare Diagnostics
• Thermo Fisher Scientific
• Vela Diagnostics
• Ventana Medical Systems (Roche)

For more information about this report visit http://www.researchandmarkets.com/research/qbg778/the_world_market

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Healthcare Services, Infectious Disease Testing, Blood Banking, Molecular Diagnostics